Search results
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 16 minutes agolongest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
The Motley Fool via AOL· 1 day agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
AstraZeneca (NASDAQ:AZN) Now Covered by Analysts at The Goldman Sachs Group
ETF DAILY NEWS· 8 hours agoThe Goldman Sachs Group assumed coverage on shares of AstraZeneca (NASDAQ:AZN – Free Report) in a research report report published on Thursday morning, Marketbeat Ratings ...
New antibiotic based on AstraZeneca drugs kills off deadly bacteria, spares the good guys
FierceBiotech· 4 hours agoA new antibiotic based on drugs developed by AstraZeneca can kill off dangerous bacteria that cause...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 2 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
The Motley Fool via AOL· 2 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca...
AstraZeneca stock upgraded by Goldman, 27% upside seen By Investing.com
Investing.com· 1 day agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN)...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Market Watch· 1 day agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a...
AstraZeneca shares target raised by Argus on new drug approvals By Investing.com
Investing.com· 1 day agoOn Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a market...
Analyst Report: AstraZeneca PLC
Argus Research via Yahoo Finance· 1 day agoAstraZeneca is a British-Swedish company with its main headquarters in the U.K. and regional headquarters in Sweden and the U.S. It focuses on treatments for respiratory, ...